Development and Validation of a UPLC-MS/MS Method for Almonertinib with Its Active Metabolite HAS-719 and Anlotinib in Human Plasma.
Journal of pharmaceutical and biomedical analysis（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined